^
    Back
    Association details:
    Biomarker:TMB-H
    Cancer:Head and Neck Cancer
    Drug:Keytruda (pembrolizumab) (PD1 inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Excerpt:
    Useful in Certain Circumstances:….Pembrolizumab (for MSI-H, dMMR, or TMB-H [≥10 mut/Mb] tumors)